These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37430220)

  • 1. Estimating hepatitis B virus prevalence among key population groups for European Union and European Economic Area countries and the United Kingdom: a modelling study.
    Trickey A; Bivegete S; Duffell E; McNaughton AL; Nerlander L; Walker JG; Fraser H; Hickman M; Vickerman P; Brooks-Pollock E; Christensen H
    BMC Infect Dis; 2023 Jul; 23(1):457. PubMed ID: 37430220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B/C in the countries of the EU/EEA: a systematic review of the prevalence among at-risk groups.
    Falla AM; Hofstraat SHI; Duffell E; Hahné SJM; Tavoschi L; Veldhuijzen IK
    BMC Infect Dis; 2018 Feb; 18(1):79. PubMed ID: 29433454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimates of hepatitis B virus prevalence among general population and key risk groups in EU/EEA/UK countries: a systematic review.
    Bivegete S; McNaughton AL; Trickey A; Thornton Z; Scanlan B; Lim AG; Nerlander L; Fraser H; Walker JG; Hickman M; Vickerman P; Johnson H; Duffell E; Brooks-Pollock E; Christensen H
    Euro Surveill; 2023 Jul; 28(30):. PubMed ID: 37498533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of hepatitis C infection among the general population and high-risk groups in the EU/EEA: a systematic review update.
    Han R; Zhou J; François C; Toumi M
    BMC Infect Dis; 2019 Jul; 19(1):655. PubMed ID: 31337339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening.
    Hahné SJ; Veldhuijzen IK; Wiessing L; Lim TA; Salminen M; Laar Mv
    BMC Infect Dis; 2013 Apr; 13():181. PubMed ID: 23597411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current prevalence of chronic hepatitis B and C virus infection in the general population, blood donors and pregnant women in the EU/EEA: a systematic review.
    Hofstraat SHI; Falla AM; Duffell EF; Hahné SJM; Amato-Gauci AJ; Veldhuijzen IK; Tavoschi L
    Epidemiol Infect; 2017 Oct; 145(14):2873-2885. PubMed ID: 28891457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating the scale of chronic hepatitis C virus infection in the EU/EEA: a focus on migrants from anti-HCV endemic countries.
    Falla AM; Ahmad AA; Duffell E; Noori T; Veldhuijzen IK
    BMC Infect Dis; 2018 Jan; 18(1):42. PubMed ID: 29338702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV seroprevalence in five key populations in Europe: a systematic literature review, 2009 to 2019.
    Stengaard AR; Combs L; Supervie V; Croxford S; Desai S; Sullivan AK; Jakobsen SF; Santos Q; Simões D; Casabona J; Lazarus JV; de Wit JBF; Amort FM; Pharris A; Nerlander L; Raben D
    Euro Surveill; 2021 Nov; 26(47):. PubMed ID: 34823636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The global prevalence of hepatitis D virus infection: Systematic review and meta-analysis.
    Stockdale AJ; Kreuels B; Henrion MYR; Giorgi E; Kyomuhangi I; de Martel C; Hutin Y; Geretti AM
    J Hepatol; 2020 Sep; 73(3):523-532. PubMed ID: 32335166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of HIV, HCV and HBV in Central Asia and the Caucasus: A systematic review.
    Davlidova S; Haley-Johnson Z; Nyhan K; Farooq A; Vermund SH; Ali S
    Int J Infect Dis; 2021 Mar; 104():510-525. PubMed ID: 33385583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and estimation of hepatitis B and C infections in the WHO European Region: a review of data focusing on the countries outside the European Union and the European Free Trade Association.
    Hope VD; Eramova I; Capurro D; Donoghoe MC
    Epidemiol Infect; 2014 Feb; 142(2):270-86. PubMed ID: 23714072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between the prevalence of chronic hepatitis B among people who inject drugs and country-level characteristics: An ecological analysis.
    Syangbo A; Hickman M; Colledge-Frisby S; Leung J; Grebely J; Larney S; Degenhardt L; Trickey A
    Drug Alcohol Rev; 2023 Mar; 42(3):569-581. PubMed ID: 36600489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B, hepatitis C and HIV prevalence and related sexual and substance use risk practices among key populations who access HIV prevention, treatment and related services in South Africa: findings from a seven-city cross-sectional survey (2017).
    Scheibe A; Young K; Versfeld A; Spearman CW; Sonderup MW; Prabdial-Sing N; Puren A; Hausler H
    BMC Infect Dis; 2020 Sep; 20(1):655. PubMed ID: 32894072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B and C prevalence and incidence in key population groups with multiple risk factors in the EU/EEA: a systematic review.
    Mason LM; Duffell E; Veldhuijzen IK; Petriti U; Bunge EM; Tavoschi L
    Euro Surveill; 2019 Jul; 24(30):. PubMed ID: 31362808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B virus infection in EU/EEA and United Kingdom prisons: a descriptive analysis.
    Nakitanda AO; Montanari L; Tavoschi L; Mozalevskis A; Duffell E
    Epidemiol Infect; 2021 Jan; 149():e59. PubMed ID: 33487201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review.
    Degenhardt L; Peacock A; Colledge S; Leung J; Grebely J; Vickerman P; Stone J; Cunningham EB; Trickey A; Dumchev K; Lynskey M; Griffiths P; Mattick RP; Hickman M; Larney S
    Lancet Glob Health; 2017 Dec; 5(12):e1192-e1207. PubMed ID: 29074409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B infection prevalence by country of birth in migrant populations in a large UK city.
    Cochrane A; Evlampidou I; Irish C; Ingle SM; Hickman M
    J Clin Virol; 2015 Jul; 68():79-82. PubMed ID: 26071342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of chronic HCV infection in EU/EEA countries in 2019 using multiparameter evidence synthesis.
    Thomadakis C; Gountas I; Duffell E; Gountas K; Bluemel B; Seyler T; Pericoli FM; Kászoni-Rückerl I; El-Khatib Z; Busch M; Schmutterer I; Vanwolleghem T; Klamer S; Plettinckx E; Mortgat L; Van Beckhoven D; Varleva T; Kosanovic Licina ML; Nemeth Blazic T; Nonković D; Theophanous F; Nemecek V; Maly M; Christensen PB; Cowan S; Rüütel K; Brummer-Korvenkontio H; Brouard C; Steffen G; Krings A; Dudareva S; Zimmermann R; Nikolopoulou G; Molnár Z; Kozma E; Gottfredsson M; Murphy N; Kondili LA; Tosti ME; Ciccaglione AR; Suligoi B; Nikiforova R; Putnina R; Jancoriene L; Seguin-Devaux C; Melillo T; Boyd A; van der Valk M; Op de Coul E; Whittaker R; Kløvstad H; Stępień M; Rosińska M; Valente C; Marinho RT; Popovici O; Avdičová M; Kerlik J; Klavs I; Maticic M; Diaz A; Del Amo J; Lundberg Ederth J; Axelsson M; Nikolopoulos G
    Lancet Reg Health Eur; 2024 Jan; 36():100792. PubMed ID: 38188273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between universal hepatitis B prison vaccination, vaccine uptake and hepatitis B infection among people who inject drugs.
    Palmateer NE; Goldberg DJ; Munro A; Taylor A; Yeung A; Wallace LA; Mitchell A; Shepherd SJ; Gunson RN; Aitken C; Hutchinson SJ
    Addiction; 2018 Jan; 113(1):80-90. PubMed ID: 28710874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.